Trading: Short Peloton, the one-trick pony
Exercise-bike maker Peloton faces stiff competition and is hugely overpriced, says Matthew Partridge.
The crisis has given many technology stocks a big boost. One of the biggest turnarounds has occurred at Peloton (Nasdaq: PTON), which makes expensive exercise bikes that come with streamed workout lessons. In late 2019 a disastrous advertising campaign had left it widely mocked, with many speculating that it was only the latest in a string of overhyped stocks. However, the pandemic and the subsequent closure of gyms has created huge demand for home-exercise equipment, propelling Peloton’s stock from $25 at the start of the year to a peak of $68.
Peloton may have done well during the crisis, with the company’s management talking about “holiday-like demand”, but its future looks more uncertain, especially with countries around the world (including the UK) starting to reopen gyms as part of a wider effort to stimulate the economy. Of course, many people may still be reluctant to visit the gym, or feel uncomfortable with the social-distancing requirements still in place. However, the rapid progression of multiple vaccine trials around the world means that there is a realistic prospect of a return to pre-crisis normality by the end of the year, which could mean that sales growth slows, or even reverses.
Stiff competition awaits
However, even if a second wave of the virus causes governments to shut things down again, or many people decide to stay home for good – prolonging the boom in home-exercise equipment – there’s still no guarantee that Peloton will be the big winner from all of this. It not only faces stiff competition from companies selling similar products – Hydrow, for instance – but also from makers of exercise apps, such as Apple and Zwift. Exercise apps, which allow people to stream classes over laptops and tablets, or take part in virtual races, have several advantages over Peloton. They facilitate a wider range of activities than just cycling. More importantly, apps allow users to use existing equipment instead of spending $2,000 on a new exercise bike (something that they may be loath to do in a recession).
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Even if Peloton does become the dominant force in home exercise, it still looks aggressively priced, trading at 5.3 times projected 2021 sales. And note that despite a 66% year-on-year surge in sales in the first quarter, Peloton still hasn’t found a way to make the company profitable. It is expected to lose $131m this year and $96m in 2021. This is partly because the profits on the machines are offset by the huge amount that Peloton is spending on marketing in an attempt to win new customers.
Peloton’s shares currently trade at $60, around 16% down from their peak at $68 earlier this month, suggesting that the market seems to be starting to cool on the company. I recommend that you short Pelton at its current price, to the tune of £33 per $1. If you cover your short at $90, this would give you a potential downside of £990.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Energy bills to rise by 1.2% in January 2025
Energy bills are set to rise 1.2% in the New Year when the latest energy price cap comes into play, Ofgem has confirmed
By Dan McEvoy Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Should you invest in Trainline?
Ticket seller Trainline offers a useful service – and good prospects for investors
By Dr Matthew Partridge Published
-
Harworth doubles profit as revenue soars – should you buy?
Harworth, a specialist property developer, is well-aligned with government policies, with revenue expected to rise by over 50% this year, and a further 30% the year after.
By Dr Matthew Partridge Published
-
Bitcoin miner Riot Platforms bleeds money – what happens now?
Riot Platforms struggles to make a profit and looks absurdly overvalued. Are troubles brewing?
By Dr Matthew Partridge Published
-
M&S recovery has momentum: will it stick?
After years of decline, M&S seems to have turned a corner. But is this just a “dead cat bounce”?
By Dr Matthew Partridge Published
-
Is Alpha Group a good buy?
Alpha Group helps clients manage risks such as foreign exchange. After being promoted to the London Stock Exchange, does the stock still rally?
By Dr Matthew Partridge Published
-
Vistry sales improve – should you buy into the boom?
Housebuilder Vistry’s unusual business model has fuelled rapid sales growth amid a sluggish private sales market
By Dr Matthew Partridge Published
-
Ocado shares plunge after FTSE 100 demotion
Ocado remains unprofitable and overvalued. Is it time to let go of the online supermarket?
By Dr Matthew Partridge Published
-
Should you invest in Axos Bank?
Axos Financial is highly exposed to America’s commercial-property slump
By Dr Matthew Partridge Published